BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 24564859)

  • 21. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
    Wang HY; Zhang ZX
    Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the expression and function of Syk and VEGF-C in the development of non-small cell lung cancer].
    Guo JZ; Sun QF; Cong B; Zhao YP; Peng CL; Zhao XG
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(47):3801-3. PubMed ID: 24548403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
    Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
    Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
    Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
    Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
    Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
    Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemia.
    Boros K; Puissant A; Back M; Alexe G; Bassil CF; Sinha P; Tholouli E; Stegmaier K; Byers RJ; Rodig SJ
    Oncotarget; 2015 Sep; 6(28):25575-87. PubMed ID: 26315286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
    Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
    Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. System analysis identifies distinct and common functional networks governed by transcription factor ASCL1, in glioma and small cell lung cancer.
    Donakonda S; Sinha S; Dighe SN; Rao MRS
    Mol Biosyst; 2017 Jul; 13(8):1481-1494. PubMed ID: 28742165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARHGEF19 regulates MAPK/ERK signaling and promotes the progression of small cell lung cancer.
    Wang Z; Kan G; Sheng C; Yao C; Mao Y; Chen S
    Biochem Biophys Res Commun; 2020 Dec; 533(4):792-799. PubMed ID: 32993957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
    Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
    Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
    Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
    Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and methylation status of the Syk gene in cervical carcinoma.
    Zhao S; Sun G; Tony PW; Ma D; Zhao C
    Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
    Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
    Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
    Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
    Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung.
    Wang WZ; Shilo K; Amann JM; Shulman A; Hojjat-Farsangi M; Mellstedt H; Schultz J; Croce CM; Carbone DP
    Cell Death Dis; 2021 Jun; 12(6):577. PubMed ID: 34088900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway.
    Li L; Song W; Yan X; Li A; Zhang X; Li W; Wen X; Zhou L; Yu D; Hu JF; Cui J
    Oncotarget; 2017 Jun; 8(26):41975-41987. PubMed ID: 28410216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.
    Xia TS; Shi JP; Ding Q; Liu XA; Zhao Y; Liu YX; Xia JG; Wang S; Ding YB
    Med Oncol; 2012 Jun; 29(2):448-53. PubMed ID: 21347717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer.
    Wang X; Li X; Niu L; Lv F; Guo T; Gao Y; Ran Y; Huang W; Wang B
    Oncogene; 2024 May; 43(22):1669-1687. PubMed ID: 38594505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive genomic profiles of small cell lung cancer.
    George J; Lim JS; Jang SJ; Cun Y; Ozretić L; Kong G; Leenders F; Lu X; Fernández-Cuesta L; Bosco G; Müller C; Dahmen I; Jahchan NS; Park KS; Yang D; Karnezis AN; Vaka D; Torres A; Wang MS; Korbel JO; Menon R; Chun SM; Kim D; Wilkerson M; Hayes N; Engelmann D; Pützer B; Bos M; Michels S; Vlasic I; Seidel D; Pinther B; Schaub P; Becker C; Altmüller J; Yokota J; Kohno T; Iwakawa R; Tsuta K; Noguchi M; Muley T; Hoffmann H; Schnabel PA; Petersen I; Chen Y; Soltermann A; Tischler V; Choi CM; Kim YH; Massion PP; Zou Y; Jovanovic D; Kontic M; Wright GM; Russell PA; Solomon B; Koch I; Lindner M; Muscarella LA; la Torre A; Field JK; Jakopovic M; Knezevic J; Castaños-Vélez E; Roz L; Pastorino U; Brustugun OT; Lund-Iversen M; Thunnissen E; Köhler J; Schuler M; Botling J; Sandelin M; Sanchez-Cespedes M; Salvesen HB; Achter V; Lang U; Bogus M; Schneider PM; Zander T; Ansén S; Hallek M; Wolf J; Vingron M; Yatabe Y; Travis WD; Nürnberg P; Reinhardt C; Perner S; Heukamp L; Büttner R; Haas SA; Brambilla E; Peifer M; Sage J; Thomas RK
    Nature; 2015 Aug; 524(7563):47-53. PubMed ID: 26168399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.